Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$3.87 -0.23 (-5.61%)
At close: Nov 11, 2026 · 4:00 PM EST

Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) posted Return on Capital Employed [ROCE] of -73.45% for Q2 2026, down 25.29 percentage points from -48.16% a year earlier and down 9.90 percentage points from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, Tonix Pharmaceuticals Holding's Return on Capital Employed [ROCE] came in at -66.44%, up 30.95 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +42.06 percentage points (FY2020 to FY2025).
  • In prior years, Tonix Pharmaceuticals Holding's Return on Capital Employed [ROCE] was -97.39% in FY2024 (-28.24 pp), -69.15% in FY2023 (-17.04 pp), -52.11% in FY2022 (+10.34 pp) and -62.45% in FY2021 (+46.06 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of +27.67 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2025, with a gain of 159.57 percentage points; the weakest was Q3 2024, with a drop of 115.87 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -63.55% (Q1 2026), -53.73% (Q4 2025) and -50.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Tonix Pharmaceuticals Holding 78.52 Mn -653.62 Mn 15.98 Mn -91.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -91.06%
Jun 30, 2026 -73.45%
Mar 31, 2026 -63.55%
Dec 31, 2025 -53.73%
Sep 30, 2025 -50.23%
Jun 30, 2025 -48.16%
Mar 31, 2025 -79.29%
Dec 31, 2024 -123.56%
Sep 30, 2024 -209.81%
Jun 30, 2024 -190.81%
Mar 31, 2024 -85.06%
Dec 31, 2023 -92.49%
Sep 30, 2023 -93.93%
Jun 30, 2023 -82.95%
Mar 31, 2023 -63.15%
Dec 31, 2022 -51.90%
Sep 30, 2022 -44.23%
Jun 30, 2022 -41.78%
Mar 31, 2022 -45.18%
Dec 31, 2021 -44.79%
API Access

Tonix Pharmaceuticals Holding Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TNXP&period=max&api_key=YOUR_API_KEY